StockData

Akso Health vs Ucommune International

AHG and UK side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AHG and UK compare

Akso Health grew revenue faster over the last twelve months (−6.4% versus −66.2% for Ucommune International).

Akso Health scores higher on the StockData Score (7 against 5 for Ucommune International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAHGUK
Size and price
Share price$1.24$1.44
Change, 1 year−17.9%−83.4%
Change, 5 years−57.7%−99.9%
Beta (5Y)0.530.57
Employees1242
StockData Score
Total score7 (better)5
Valuation score00
Growth score1 (better)0
Performance score1 (better)0
Health score55
Dividend score00
Growth
Revenue growth (TTM)−6.4% (better)−66.2%
Revenue growth, 5Y average51.1% (better)−50.5%
EPS growth (TTM)−93.8%–
Profitability
Gross margin−0.08% (better)−2.9%
Operating margin−150% (better)−155%
Net margin−135%–
FCF margin−92.5%−80.8% (better)
Return on equity−9.8%–
Return on invested capital−16.1% (better)−31.9%
Financial health
Debt / equity0.000.00
Current ratio21.77 (better)1.07
Piotroski F-score5–
Ownership
Held by institutions0.01%–
Held by insiders0.00%0.00%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.